Phase 3 Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been confirmed through a tissue test to have a type of cancer called diffuse large B-cell lymphoma (DLBCL)
- People who have already received at least one round of treatment for their cancer
- People who have at least one measurable area of cancer that can be tracked in two directions (confirm with trial site)
- People whose doctors expect them to live for at least 3 months
- People who are 18 years of age or older but under 80 years of age
- People who are willing to take part voluntarily, sign a consent form, follow the study requirements, and attend follow-up appointments
Who may not be able to join:
- People whose lymphoma has spread to the central nervous system (the brain or spinal cord)
- People whose lymphoma started in the area behind the breastbone (the mediastinum/thymus region)
- People who have only had one prior treatment and whose doctors consider them suitable candidates for a stem cell transplant
- People who have a history of immune system deficiency
- People who have a history of serious heart or cardiovascular disease
- People who have been diagnosed with another type of cancer within the last 5 years
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86-0518-82342973
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Complete response rate (CRR); Overall survival (OS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.